These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 4401160)

  • 1. Effects of sympathetic and central nervous system alterations on the blood pressure responses to phentolamine.
    Hilliard CC; Bagwell EE; Daniell HB
    J Pharmacol Exp Ther; 1972 Mar; 180(3):743-7. PubMed ID: 4401160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological action of 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrolinone hydrochloride (doxapram). 1. The action on the central nervous system].
    Kuga T; Naito J
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):701-10. PubMed ID: 4148712
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that phentolamine acts centrally to increase the contractile force of the heart.
    Hilliard CC; Bagwell EE; Daniell HB
    Eur J Pharmacol; 1972 May; 18(3):338-45. PubMed ID: 4624702
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).
    Privitera PJ; Blickenstaff T; Gaffney TE; Mohammed S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):655-61. PubMed ID: 4398744
    [No Abstract]   [Full Text] [Related]  

  • 6. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the central nervous system in the cardiovascular responses to yohimbine.
    Lang WJ; Lambert GA; Rush ML
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):57-67. PubMed ID: 242288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the pressor and tachycardiac effects of ketamine. 1. Effects of sympathetic nerve inhibition].
    Saito T; Wakisaka K; Hirano T
    Masui; 1971 Sep; 20(9):833-41. PubMed ID: 5166766
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of regitine on the frequency of plethysmographic alpha waves.
    Stancák A; Schweitzer R; Medvecká E
    Act Nerv Super (Praha); 1971; 13(3):205-6. PubMed ID: 4398845
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the sympathetic nervous system in the cardiovascular effects of cocaine.
    Gillis RA; Bachenheimer LC; Dretchen KL; Erzouki HK; Hernandez YM; Jain RK; Jain MK; Kuhn FE; Quest J; Schaer GL
    NIDA Res Monogr; 1991; 108():92-109. PubMed ID: 1749420
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac slowing effects of clonidine (ST-155) in dogs.
    Scriabine A; Stavorski J; Wenger HC; Torchiana ML; Stone CA
    J Pharmacol Exp Ther; 1970 Feb; 171(2):256-64. PubMed ID: 5272380
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of reserpine on the cardiovascular responses to phentolamine.
    Hilliard CC; Bagwell EE; Daniell HB; Freeman BF
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):55-63. PubMed ID: 5059369
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of the cardiovascular response to isoproterenol by pilocarpine.
    Daniell HB; Bagwell EE
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):141-52. PubMed ID: 5350777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of sympathetic nerve system and skeletal muscles in theophylline-induced thermogenesis. Studies on non-shivering thermogenesis. 2 (author's transl)].
    Kurahashi M
    Nihon Seirigaku Zasshi; 1974; 36(2):62-71. PubMed ID: 4152719
    [No Abstract]   [Full Text] [Related]  

  • 15. The pressor effect of oxotremorine and arecoline in rats.
    Phan DV; György L
    Acta Physiol Acad Sci Hung; 1973; 43(1):71-84. PubMed ID: 4149154
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinterenol, a new beta adrenergic stimulant.
    Scriabine A; Moore PF; Iorio LC; Goldman IM; McShane WK; Booher KD
    J Pharmacol Exp Ther; 1968 Jul; 162(1):60-9. PubMed ID: 4385348
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of lidocaine, hexamethonium and alpha and beta adrenergic blocking agents on the pulmonary veins in intact dogs.
    Hyman AL
    J Pharmacol Exp Ther; 1970 Sep; 174(3):487-99. PubMed ID: 5456181
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular cholinergic receptor systems: interaction with adrenergic systems.
    Dempsey PJ; Cooper T
    J Pharmacol Exp Ther; 1969 Jun; 167(2):282-90. PubMed ID: 5787867
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous responses to prostaglandin F2 alpha.
    Mark AL; Schmid PG; Eckstein JW; Wendling MG
    Am J Physiol; 1971 Jan; 220(1):222-6. PubMed ID: 4992254
    [No Abstract]   [Full Text] [Related]  

  • 20. Actions of bretylium tosylate on the cardiovascular system of the dog.
    Richmond DR; Angus JA; Goodman AH; Cobbin LB
    Cardiovasc Res; 1973 Jan; 7(1):47-54. PubMed ID: 4694956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.